HEPHL1: A Potential Drug Target and Biomarker (G341208)

Target Name: HEPHL1

NCBI ID: G341208

HEPHL1

HEPHL1: A Potential Drug Target and Biomarker

Hephaestin-like protein 1 (HEPHL1) is a protein that is expressed in various tissues and has been shown to play a role in a number of cellular processes.HEPHL1 has been identified as a potential drug target and biomarker due to its unique structure and biology.

The protein encoded by the HEPHL1 gene is a 21 kDa protein that is characterized by a predicted transmembrane domain and a cytoplasmic tail.HEPHL1 is a member of the heat shock protein (HSP) family, which is known for their ability to survive and function in extreme temperatures and stress conditions.

HEPHL1 has been shown to be involved in a number of cellular processes, including cell signaling, DNA replication, and protein synthesis.HEPHL1 has also been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and invasion.

As a potential drug target, HEPHL1 is of interest because of its unique structure and biology.HEPHL1 is a small protein that is expressed in a variety of tissues, including muscle, heart, brain, and testes.HEPHL1 is also known to be involved in the regulation of a number of cellular processes, making it an attractive target for small molecule inhibitors.

In addition to its potential as a drug target, HEPHL1 is also a potential biomarker.HEPHL1 has been shown to be expressed in a variety of cancer types, including breast, lung, and ovarian cancer.HEPHL1 has also been shown to be involved in the regulation of cellular processes that are often disrupted in cancer, such as cell signaling and protein synthesis.

The discovery and characterization of HEPHL1 as a potential drug target and biomarker has the potential to lead to new treatments for a variety of diseases.Further research is needed to fully understand the biology and pharmacology of HEPHL1, as well as the development of small molecule inhibitors that can target this protein.

Protein Name: Hephaestin Like 1

Functions: Is a copper-binding glycoprotein with ferroxidase activity. It oxidizes Fe(2+) to Fe(3+) without releasing radical oxygen species (PubMed:31125343). May be involved in the regulation of intracellular iron content (PubMed:31125343)

The "HEPHL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HEPHL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets